Yugang Fu
Yugang Fu is a PhD student in the Department of Pharmacology & Therapeutics. His background includes clinical medicine and statistics. Currently, Yugang is focused on pharmacokinetic-pharmacodynamic (PKPD) modelling and quantitative systems pharmacology, specifically targeting drug development for pancreatic cancer. He is dedicated to leveraging his clinical background and research skills to contribute to innovative therapeutic strategies in this challenging field.
Olivia Harris
Olivia is currently pursuing a PhD in Pharmacology at the University of Liverpool. She obtained a BSc in Clinical Pharmacology from St George’s University of London before undertaking her ITTP funded PhD, in collaboration with GSK. Her research focuses on investigating inter-patient variability of the Nrf2 pathway and its effect on drug toxicity. Olivia combines both wet lab and mathematical modelling techniques in her research, aiming to improve safety in drug development, reduce attrition rates and ultimately contribute towards more effective and safe therapies.
Ivan Ibanda
Ivan holds a bachelor’s degree in biomedical sciences, a PGD in Clinical Trials and MSc in Pharmacology. His experiences are mainly in academic settings as a laboratory professional and teacher. He has conducted projects involving fungal, bacterial, and viral pathogens. Currently a PhD student, Ivan is investigating the systems biology of thioredoxin reductase inhibition, aiming to develop new antifungal therapies with minimal toxicity to mammalian cells, utilizing mathematical modelling to further this research.
Zijin Lin
Zijin obtained a Master degree in Pharmacokinetics in 2024. During her degree, she focused on transporter alterations under disease conditions, aiming to reveal inner mechanisms of changes in pharmacokinetics and drug efficacy. She was also involved in several projects, including in vitro drug-drug interaction (DDI) and in vivo ADME research. Now, she is studying for her PhD, aiming to develop and validate a pharmacokinetics/pharmacodynamics (PK/PD) modelling with genomic markers and clinical information to optimise drug dosing regimen in multimorbid patients.
Nadda Muhamad
I am an Honorary Research Fellow (nominated by Dr. Tao You) in the Department of Pharmacology & Therapeutics. I graduated from Srinakharinwirot University, Thailand, with a B.Pharm degree in 2012 and earned my Ph.D. in Bioclinical Sciences from Thammasat University, Thailand, in 2023. My previous research focused on the clinical pharmacokinetics and drug metabolism of herbal medicines. Currently, I am concentrating on mathematical modeling, specifically PBPK modeling of vitamin D, with the aim of determining the optimal dosage for both adult and pediatric populations.